Clinical Trials
22 trialsHEM-DOAC
Medical University of Gdansk
Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
PREVENT-GU
Ottawa Hospital Research Institute
TRIM-Line
Ottawa Hospital Research Institute
TRIM-Line
Ottawa Hospital Research Institute
ROSIE
Radboud University Medical Center
RithMM
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Efficacy and Safety of Rivaroxaban in the Prevention of Venous Thromboembolism in Glioma Patients
Nanfang Hospital, Southern Medical University
CAT_PB
Lebanese University
CANVAS
Alliance Foundation Trials, LLC.
Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis
Medical College of Wisconsin
Ésquilo
Hospital do Servidor Publico Estadual
PRO-LAPSII
Fadoi Foundation, Italy
VALERIA
Science Valley Research Institute
Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer Patients
AIO-Studien-gGmbH
Prophylactic Anticoagulation for Catheter-related Thrombosis
Second Affiliated Hospital, School of Medicine, Zhejiang University
Rivaroxaban for Thromboprophylaxis in High-risk Cancer Patients With Totally Implantable Access Ports
LiuZhou People's Hospital
PRIORITY
Asan Medical Center
Rivaroxaban Versus Low-molecular-weight Heparin for Preventing Thrombosis in Cancer Patients
Capital Medical University
CASTA-DIVA
Assistance Publique - Hôpitaux de Paris
Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer
Seoul National University Hospital
Study in Cancer Patients With Central Line Associated Clots in the Upper Extremity Treated With Rivaroxaban (Catheter 2)
London Health Sciences Centre